ArticleFrontiers in immunology2021

Case Report: Complete Response of Primary Massive Hepatocellular Carcinoma to Anti-Programmed Death Ligand-1 Antibody Following Progression on Anti-Programmed Death-1 Antibody.

Gang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.